Wells Fargo’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$155K Sell
16,931
-33,703
-67% -$283K ﹤0.01% 4856
2025
Q4
$377K Buy
50,634
+21,564
+74% +$155K ﹤0.01% 4683
2025
Q3
$194K Buy
29,070
+4,494
+18% +$31.2K ﹤0.01% 4946
2025
Q2
$163K Buy
24,576
+2,510
+11% +$17.8K ﹤0.01% 4890
2025
Q1
$202K Sell
22,066
-428
-2% -$4.28K ﹤0.01% 4695
2024
Q4
$236K Buy
22,494
+5,459
+32% +$64.6K ﹤0.01% 4693
2024
Q3
$204K Buy
17,035
+2,153
+14% +$18.6K ﹤0.01% 4567
2024
Q2
$85.6K Buy
14,882
+14,626
+5,713% +$80.2K ﹤0.01% 5026
2024
Q1
$1.33K Buy
256
+4
+2% +$20 ﹤0.01% 6093
2023
Q4
$1.33K Buy
252
+14
+6% +$55 ﹤0.01% 6162
2023
Q3
$785 Buy
238
+8
+3% +$28 ﹤0.01% 6253
2023
Q2
$665 Sell
230
-5,448
-96% -$10.5K ﹤0.01% 6425
2023
Q1
$6.08K Buy
5,678
+5,160
+996% +$9.87K ﹤0.01% 6001
2022
Q4
$1.35K Sell
518
-296,927
-100% -$1.3M ﹤0.01% 6096
2022
Q3
$2.08M Sell
297,445
-12,100
-4% -$94.7K ﹤0.01% 2707
2022
Q2
$2.11M Buy
309,545
+291,963
+1,661% +$2.98M ﹤0.01% 2739
2022
Q1
$248K Sell
17,582
-9,842
-36% -$132K ﹤0.01% 4862
2021
Q4
$398K Sell
27,424
-158,205
-85% -$2.25M ﹤0.01% 4847
2021
Q3
$2.63M Buy
185,629
+37,127
+25% +$571K ﹤0.01% 3436
2021
Q2
$2.61M Buy
148,502
+146,094
+6,067% +$2.35M ﹤0.01% 3444
2021
Q1
$37K Buy
+2,408
New +$34.3K ﹤0.01% 5945

Other funds holding BVS